Number of Cancer Stem Cells Might Not Predict Outcome in HPV-Related Oral Cancers
COLUMBUS, Ohio – New research from The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) suggests that it ma
Ohio State Awarded $11.3 Million for Thyroid Cancer Research
Prestigious National Cancer Institute SPORE grant third for cancer center
COLUMBUS, Ohio –The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital
AML Score That Combines Genetic and Epigenetic Changes Might Help Guide Therapy
Guido Marcucci, MD
Currently, treatments for adult acute myeloid leukemia (AML) are determined mainly using the chromosome changes and gene mutations present in AML cells.
In this study, researchers
Laboratory Study Confirms Target of Potent Chronic Leukemia Drug
Jennifer Woyach, MD
The experimental drug ibrutinib can be exceptionally effective in treating chronic leukemia, but it is unclear whether its primary target, a molecule called BTK, is important for
Tomato-Rich Diet Increases Hormone Linked to Reduced Breast Cancer Risk in Postmenopausal Women
COLUMBUS, Ohio – A tomato-rich diet could help protect at-risk postmenopausal women from breast cancer, according to new research from The Ohio State University Comprehensive Cancer Center – Arthur G.
Pelotonia Riders Pedal to a Record $19 Million for Cancer Research
Fundraising total of $61 million for first five years
COLUMBUS, Ohio - Pelotonia has announced record fundraising of more than $19 million for its 2013 ride.
From August 10-11, 2013, 6,723
Nine More Big Ideas in Cancer Research at Ohio State Funded by Pelotonia
COLUMBUS, OHIO—New treatments that target markers in individual cancers; packaging a novel leukemia drug in nano-sized bubbles of fat; and a national cancer disparities research network are among the
Next-Generation Genome Screening Is Step Toward Precision Cancer Medicine for Lung Cancer
DNA analysis helps doctors identify drugs to more precisely target individual patient tumors
COLUMBUS, Ohio – Precision cancer medicine has taken a strong step forward at the Ohio State Universi
HPV Can Damage Genes and Chromosomes Directly, Sequencing Study Shows
Maura Gillison, MD, PhD
Human papillomavirus (HPV) causes cervical, head and neck, anal and other cancers.
How it causes cancer isn’t completely known.
This study shows that HPV can damage genes a
Ohio State Trial Tests Novel Two-Drug Combination for Triple Negative Breast Cancers
COLUMBUS, Ohio -- Breast cancer researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital & Richard J. Solove Research Institute (OSUCCC – James) are test
Genomic Medicine Pioneer to Present Annual Block Lecture at Ohio State
COLUMBUS, Ohio – Eric S. Lander, PhD, president and founding director of the Broad Institute of the Massachusetts Institute of Technology and Harvard University, will receive the 20th annual Herbert a
Cancer Wasting Due in Part to Tumor Factors That Block Muscle Repair, Study Shows
Cancer wasting causes 20-25 percent of cancer deaths.
Tumor growth causes the condition, which has no treatment.
This study shows that cancer wasting is due in part to tumor factors that block muscl
Ohio State Testing a New Spice Derivative Formulation for Breast Cancer Prevention
COLUMBUS, Ohio – A clinical trial at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) investigates wh
Minimally Invasive Surgery Helps Young Cancer Patients Maintain Fertility
COLUMBUS, Ohio – Although the human papillomavirus (HPV) vaccine, pap smears and increased public awareness have reduced cervical cancer rates in the United States, the disease still affects at least
Ohio State’s James Cancer Hospital Receives Highest Nursing Recognition With Prestigious Magnet® Designation
COLUMBUS, Ohio - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has achieved Magnet® designation as
The Ohio State University Partners with Microlin Bio Inc. to Bring the University’s Transformational Cancer Discoveries to Patients
Largest Ohio State licensing agreement in more than a decade
COLUMBUS, Ohio, and NEW YORK–The Ohio State University today announced the signing of an exclusive world-wide agreement with Microlin
MicroRNA-31 Might Predict Lung-Cancer Spread
Determining whether lung cancer has spread is critical for identifying the most effective therapy.
This study found that high levels of microRNA-31 indicate that the tumor has spread and signals a p
Ohio State Receives $18.7 Million Federal Grant to Establish Tobacco Center of Regulatory Science
Multidisciplinary Research Will Inform FDA in New
COLUMBUS, Ohio – The Ohio State University has received an $18.7 million federal grant to establish a research center devoted to t
MicroRNA Molecule Found to be a Potent Tumor-Suppressor in Lung Cancer
Carlo M. Croce, MD
A microRNA called miR-486 is known to play a role in several solid tumors but its mechanism of action in lung cancer is not known.
This study shows that miR-486 is a potent tumor
NCI Renews Support for Major Thyroid-Cancer Research Effort at Ohio State
COLUMBUS, Ohio – The National Cancer Institute (NCI) has awarded a five-year, $11.3 million grant to a team of researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James